Methylene Blue in the Treatment of Neuropsychiatric Disorders

Martin Alda

doi:10.1007/s40263-019-00641-3

Methylene Blue in the Treatment of Neuropsychiatric Disorders

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	719-725
Number of pages	7
Journal	CNS Drugs
Volume	33
Issue number	8
DOIs	https://doi.org/10.1007/s40263-019-00641-3
Publication status	Published - Aug 1 2019
Externally published	Yes

ASJC Scopus Subject Areas

Clinical Neurology
Psychiatry and Mental health
Pharmacology (medical)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s40263-019-00641-3

Cite this

@article{306c368cedfe49b196687d9f18f0aef1,

title = "Methylene Blue in the Treatment of Neuropsychiatric Disorders",

author = "Martin Alda",

note = "Publisher Copyright: {\textcopyright} 2019, Springer Nature Switzerland AG.",

year = "2019",

month = aug,

day = "1",

doi = "10.1007/s40263-019-00641-3",

language = "English",

volume = "33",

pages = "719--725",

journal = "CNS Drugs",

issn = "1172-7047",

publisher = "Adis International Ltd",

number = "8",

}

TY - JOUR

T1 - Methylene Blue in the Treatment of Neuropsychiatric Disorders

AU - Alda, Martin

PY - 2019/8/1

Y1 - 2019/8/1

UR - http://www.scopus.com/inward/record.url?scp=85066805872&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85066805872&partnerID=8YFLogxK

U2 - 10.1007/s40263-019-00641-3

DO - 10.1007/s40263-019-00641-3

M3 - Article

C2 - 31144270

AN - SCOPUS:85066805872

SN - 1172-7047

VL - 33

SP - 719

EP - 725

JO - CNS Drugs

JF - CNS Drugs

IS - 8

ER -

Methylene Blue in the Treatment of Neuropsychiatric Disorders

ASJC Scopus Subject Areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this